Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3b Open-Label Study of Long-Term Neurocognitive Outcomes in Children With Phenylketonuria Treated With Sepiapterin

NCT06302348 is registered in ClinicalTrials.gov with PTC Therapeutics as lead sponsor.

NCT NCT06302348
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06302348 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3b Open-Label Study of Long-Term Neurocognitive Outcomes in Children With Phenylketonuria Treated With Sepiapterin
Lead sponsor
PTC Therapeutics
Phase
Phase 3
Overall status
Recruiting
Start date
March 4, 2024
Completion date
February 28, 2031
Enrollment
56 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

phenylketonuria